Maviret

Medicinal product

(Invented) name

Maviret

Active substance (s)

Glekapreviras/Pibrentasviras

Strength

50 mg/20 mg

Pharmaceutical form

dengtos granulės paketėlyje

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J05AP57, Glecaprevir and pibrentasvir

Marketing authorisation holder

AbbVie Deutschland GmbH & Co. KG , Vokietija

Date of authorisation

2017-07-26

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Coated granules in sachet	1 vnt.
Glekapreviras	50 mg
Pibrentasviras	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
107160	93263	1093263	paketėlis	N28		Receptinis	EU/1/17/1213/003	Tiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2017-07-26	Registruotas